DIRECT COMPARISON OF TC-99M DTPA AND TC-99M HMPAO FOR EVALUATING BRAIN-DEATH

被引:27
|
作者
SPIETH, ME
ANSARI, AN
KAWADA, TK
KIMURA, RL
SIEGEL, ME
机构
[1] UNIV SO CALIF,LOS ANGELES CTY MED CTR,SCH MED,DEPT RADIOL,DIV NUCL MED,LOS ANGELES,CA 90033
[2] PACIFIC UNION COLL,ANGWIN,CA
关键词
D O I
10.1097/00003072-199410000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Portable cerebral perfusion studies provide a quick and accurate alternative to traditional confirmatory examinations (such as four-vessel angiography and electroencephalography) to determine brain death. The authors retrospectively analyzed 26 cerebral perfusion studies using both Tc-99m DTPA and Tc-99m HMPAO. The flow agents gave identical results. Additionally, the delayed-phase Tc-99m HMPAO images gave the same results for brain death (14 positive and 12 negative) as the flow images from either agent. Because the Tc-99m HMPAO delayed images can be used for diagnosis, many technical problems become less crucial. Unlike Tc-99m DTPA, Tc-99m HMPAO normally visualizes the gray mater of the cerebellum, midbrain, and medulla. These areas must be evaluated to ensure that they meet the strict criteria for brain death. These differences and the present study suggest that Tc-99m HMPAO is a superior agent for cerebral perfusion studies to determine brain death.
引用
收藏
页码:867 / 872
页数:6
相关论文
共 50 条
  • [31] QUANTITATIVE PHARMACODYNAMICS OF TC-99M POLYPHOSPHATE AND TC-99M
    COOPER, M
    SORANDES, T
    HAGAN, P
    JOURNAL OF NUCLEAR MEDICINE, 1973, 14 (08) : 624 - 624
  • [32] Tc-99m HMPAO localization in brain tumors.
    Slizofski, WJ
    Krishna, L
    McCormick, T
    Black, P
    Miyamoto, C
    Nair, S
    Kapadia, K
    Gillan, M
    Dadparvar, S
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1176 - 1176
  • [33] A COMPARISON OF 3 METHODS TO DETERMINE THE RADIOCHEMICAL PURITY OF TC-99M HEXAMETHYLPROPYLENE AMINE OXIME (TC-99M HMPAO)
    MAH, G
    REILLY, RM
    WONG, GLM
    HOULE, S
    NUCLEAR MEDICINE COMMUNICATIONS, 1989, 10 (10) : 733 - 740
  • [34] INITIAL EXPERIENCE WITH TC-99M HMPAO BRAIN SPECT
    PODREKA, I
    SUESS, E
    GOLDENBERG, G
    STEINER, M
    BRUCKE, T
    MULLER, C
    LANG, W
    NEIRINCKX, RD
    DEECKE, L
    JOURNAL OF NUCLEAR MEDICINE, 1987, 28 (11) : 1657 - 1666
  • [35] REGIONAL RENOGRAPHY WITH TC-99M DTPA
    FERLIN, G
    PERELLI, R
    BORSATO, N
    JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE, 1976, 20 (03): : 99 - 100
  • [36] LOCALIZATION OF TC-99M DTPA IN NEUROFIBROMA
    SIDDIQUI, AR
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (01) : 143 - 144
  • [37] INITIAL EXPERIENCE WITH TC-99M-HEXAMETHYLPROPYLENEAMINE OXIME (TC-99M HMPAO) BRAIN SPECT
    PODREKA, I
    SUESS, E
    GOLDENBERG, G
    STEINER, M
    BRUCKE, T
    MULLER, C
    DEECKE, L
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 887 - 888
  • [38] Dissociation of Tc-99m DTPA in a nebulizer
    Hinton, Paul J.
    Clauss, Ralf P.
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (07) : 659 - 661
  • [39] SYNOVIAL CLEARANCE OF TC-99M DTPA
    PIEPSZ, A
    HAM, HR
    JEGHERS, D
    NUCLEAR MEDICINE COMMUNICATIONS, 1982, 3 (06) : 368 - 372
  • [40] LOCALIZATION OF TC-99M DTPA IN A CHORDOMA
    GOSHEN, E
    MELLER, I
    QUASTEL, MR
    CLINICAL NUCLEAR MEDICINE, 1992, 17 (10) : 812 - 814